Evidence is graded on this page in four words: strong, moderate, emerging and limited. Medication for prostatic obstruction: strong (MTOPS, above). Behavioral treatment for overactive bladder in men: moderate (MOTIVE, above). Heat for benign enlargement: moderate for transurethral microwave thermotherapy, the urological procedure; a Cochrane review of 15 trials in 1,585 men found symptom scores fell by about two thirds with it and by about three quarters with transurethral resection (Hoffman et al., Cochrane Database Syst Rev, 2012). This review concerns urological procedures, not a service offered by St. George Hospital.
Phytotherapy: limited. In a one-year randomized trial, saw palmetto did not improve symptoms, flow, prostate size or residual volume compared with placebo (Bent et al., N Engl J Med, 2006), and a later trial of increasing doses of the extract found no benefit over placebo either (Barry et al., JAMA, 2011). The hospital uses plant extracts as supportive measures and does not rely on them to treat obstruction. Nocturia: the European guideline review found that the usual prostate and bladder drugs were generally not better than placebo for night-time voids in the short term, and that antidiuretic therapy needs a sodium check before and during treatment (Sakalis et al., above). What the evidence does not show is that any measure on this page restores a normal stream in a man with a tight obstruction; where the flow and residual volume say surgery, the physicians say so and refer you.